DarioHealth Reports Q2 Revenue, with 62% Gross Margin as AI Platform Expands
DarioHealth (DRIO:NASDAQ) reported its Q2 2026 financial results, showing US$5.2 million in revenue and a strong 62% gross margin, up from 55% in Q2 2025. The company achieved US$13.1 million in contracted and late-stage annual recurring revenue (ARR) and significantly reduced operating expenses by …